Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

UCHealth pharmacist Marissa Kim prepares a dose of the Pfizer-BioNTech COVID-19 vaccine on Feb. 20 in Denver, Colorado. Photo: Michael Ciaglo/Getty Images

Moderna and Pfizer plan to significantly boost vaccine shipments to the U.S. government by this spring, according to written testimony from company executives released Tuesday ahead of a House committee hearing on vaccines.

Where it stands: Pfizer expects to increase its weekly vaccine delivery from 4-5 million doses at the start of February to more than 13 million doses by mid-March, said John Young, Pfizer's chief business officer.

  • Moderna is working to deliver more than 40 million doses per month, doubling its current supply, and aims to ship another 100 million doses by the end of May, said Moderna president Stephen Hoge.

Between the lines: Both companies are studying potential booster shots in response to emerging coronavirus variants. Their vaccines have shown to be effective against the highly transmissible strains first seen in the U.K. and South Africa.

  • Pfizer is also studying booster effects in trial participants who have been fully vaccinated, Young said.
  • Moderna hopes to provide vaccinations to adolescents by the fall and is currently testing its vaccine's safety for children ages 12 to 18.

Be smart: The more Americans that are fully vaccinated, the faster that herd immunity will be reached — making it more difficult for the virus to spread.

Of note: Johnson & Johnson aims to make 20 million doses of its vaccine available to the government by the end of March, J&J vice president Richard Nettles testified on Tuesday. The company's one-shot vaccine is awaiting emergency use authorization from the FDA.

Go deeper on vaccines with our video short course.

Go deeper

Caitlin Owens, author of Vitals
Feb 23, 2021 - Health

Nursing home COVID cases have drastically declined

Data: The COVID Tracking Project; Chart: Michelle McGhee, Andrew Witherspoon/Axios

The number of coronavirus cases in nursing homes and assisted living facilities has drastically declined over the last two months, almost certainly an effect of vaccinations.

Why it matters: Nursing homes have been devastated by the virus, which is why residents were among the first Americans to be vaccinated.

Feb 23, 2021 - Health

Axios-Ipsos poll: Biden's window of opportunity on COVID

Data: Axios-Ipsos survey; Chart: Michelle McGhee/Axios

One month into his administration, President Biden has won the confidence of a majority of Americans in his ability to get Americans vaccinated and reopen the schools, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The catch: That confidence will only last if Americans see a clear improvement in their lives and a path back to normal, or something close to it, in the coming months.

Feb 22, 2021 - Health

Over 500,000 dead from coronavirus in U.S.


Data: CSSE Johns Hopkins University; Chart: Andrew Witherspoon/Axios

More than half a million people in the U.S. have died from the coronavirus as of Monday, according to Johns Hopkins data.

Why it matters: The death toll is larger than the total number of U.S. soldiers killed in action in World War I, World War II, and the Vietnam War combined. It comes just one year after the country's first coronavirus death was confirmed.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!